期刊文献+

奥氮平增加大鼠H9C2心肌细胞巨噬细胞迁移抑制因子基因和蛋白表达

Olanzapine augments the gene and protein expression levels of macrophage migration inhibitory factor in H9C2 cardiomyocytes
暂未订购
导出
摘要 目的通过奥氮平处理心肌细胞来探讨奥氮平诱导心血管疾病的机制。方法用不同浓度(10,20和40uM)及不同作用时间(1,3,12和24 h)的奥氮平处理大鼠心肌细胞H9C2,检测巨噬细胞迁移抑制因子(Macrophage migration inhibitory factor,MIF)在mRNA及蛋白水平的表达。结果用不同浓度、不同时间的奥氮平处理H9c2细胞时,随着处理浓度的增加及时间的延长,MIF mRNA及MIF蛋白随着浓度的递增及时间的延长而增高(P<0.05)。结论奥氮平处理心肌细胞后,MIF的mRNA及蛋白均发生显著改变,这种改变存在浓度与时间的依赖关系,MIF可能参与奥氮平诱导的心血管系统损伤。 Objective To examine the effects of olanzapine on macrophage migration inhibitory factor(MIF)expression in cardiomyocytes.Method Rat H9C2 cardiomyocytes were cultured and treated by olanzapine with different concentrations from 10 to 40 uM for different time course from 1 to 24 h.The mRNA and protein expression levels of MIF were measured at each concentration and time point.Result Both MIF mRNA and protein levels increased following olanzapine treatment in H9C2 cardiomyocytes(P<0.05)in time and dose dependent manners.Conclusion Olanzapine can increase MIF expression in cardiomyocytes,suggesting that olanzapine treatment may regulate MIF signaling and potentially affect the development of cardiovascular diseases.
作者 邢梦娟 Dake Qi 张成芳 丁文华 江开达 马端 崔东红 XING Mengjuan;Dake Qi;ZHANG Chengfang;DING Wenghua;JIANG Kaida;MA Duan;CUI Donghong(Shanghai Mental Health Center,Shanghai Jiao Tong University School of Medicine.Shanghai 230030,China)
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2012年第3期165-168,共4页 Chinese Journal of Nervous and Mental Diseases
基金 国家自然科学基金资助项目(编号:30670755,81171266) 上海市浦江人才计划(编号:10PJ1408800) 上海市科技创新计划(编号:11140900400)
关键词 巨噬细胞迁移抑制因子 奥氮平 H9C2大鼠心肌细胞系 Macrophage migration inhibitory factor Olanzapine H9C2 rat Cardiocyte cell line
  • 相关文献

参考文献17

  • 1Ananth J,Parameswaran S,Cunatilake S. Side effects of atypical antipsychotic diugs[J].Curr Phaim Des,2004,(18):2219-2229.
  • 2Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects:a comprehensive literature review[J].Cns Drugs,2005,(Suppll):1-93.
  • 3Semyak MJ,Gulanski B,Rosenheck R. Undiagnosed hyper-glycemia in patients treated with atypical antipsychotics[J].Journal of Clinical Psychiatry,2005,(11):1463-1467.
  • 4Hennekens CH,Hermekens AR,Hollar D. Schizophrenia and increased risks of cardiovascular disease^][J].American Heart Journal,2005.
  • 5Ray WA,Chung CP,Murray KT. Atypical antipsychotic drugs and the risk of sudden cardiac death[J].New England Journal of Medicine,2009,(03):225-235.
  • 6Haddad PM,Andersen IM. Antipsychotic-related QTc prolongation,Toreadedepointes and sudden death[J].Drugs,2002,(11):1649-1671.
  • 7谈艳,张少平,陈银娣.抗抑郁药和抗精神病药物所致QT间期延长和尖端扭转型室速[J].中国神经精神疾病杂志,2004,30(5). 被引量:13
  • 8Zemecke A,Bemhgen J,Weber C. Macrophage migration inhibitory factor in cardiovascular disease[J].Circulation,2008,(12):1594-1602.
  • 9Herder C,Illig T,Baumert J. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease:results from the MONICA/KORA Augsburg case-cohort study,1984-2002[J].Atheroclerosis,2008,(02):380-388.
  • 10Schober A,Bemhagen J,Thiele M. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice[J].Circulation,2004,(03):380-385.

二级参考文献18

  • 1[1]Vieweg WV. The risks of electrocardiographic QT interval prolongationwhen using antipsychotic drugs. J Clin Psychiatry, 2002, 63(suppl 9): 18.
  • 2[2]De Ponti F, Poluzzi E, Montanoro N. QT interval prolongation by cardiac or non-cardiac facters. Eur J Clin Pharmacol, 2002, 57( 1 ): 1.
  • 3[3]Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval,torsade de pointes, and sudden death, Am J Psychiatry, 2001, 158(11):1774.
  • 4[4]Pouchelon JL, Martel E, Champeroux P, et al. Effects of clomipramine hydrochloride on heart ratc and rhythm in healthy dogs. Am J Vct Res,2002, 63(8) :960.
  • 5[5]Lentinis S, Rao ML, Schroder R, et al. QT prolongation and torsa de pointes tachycardia during therapy with maprotiline. J Dtsch Med Wochencchr, 2002, 63 (8): 960.
  • 6[6]Partridge SJ, Maclever DH, Solanki T. A depressed myoeardium. J Clin Toxicol, 2002, 40(4):453.
  • 7[7]Pacher P, Magyar J, Szigligeti P, et al. Electro physidogical effects of fluoxetine in mammalian cardiac tissues. J Naunym Schmiedebergs Arch Pharmacol, 2002, 363 ( 1 ): 67.
  • 8[8]Velazquez C, Carlson A, Stokes KA, et al. Relative safety of mirtrazapine overdose. J Vet Hum Toxicol, 2002, 44(6):342.
  • 9[9]Gury C, Canceil O, Iaria P. Antipsychotic drugs and cardiovascular safety. J Encephale, 2001, 27(6):62.
  • 10[10]Ravin DS, Levenson JW. Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother, 1997, 31 (7- 8):867.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部